Interpretation of Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)

• Main Author: WANG Shan
• Format: Article
• Language: zho
• Published: Editorial Department of Journal of Clinical Hepatology 2020-05-01
• Series: Linchuang Gandanbing Zazhi
• Online Access: http://www.lcgdbzz.org/qk_content.asp?id=10767

In June 2017, the National Health and Family Planning Commission of the People’s Republic of China issued the Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition), which is of great significance as it provides recommendations on the diagnosis, staging, and treatment of liver cancer. Since then, more and more high-level evidence in accordance with the principles of evidence-based medicine has appeared in research on primary liver cancer around the world, so the National Health Commission of the People’s Republic of China revised the 2017 edition of the Guidelines and issued the Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition). This article interprets the updated key points of the new edition of the Guidelines to better guide clinical treatment.